Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

10^13th 1A

Equity
€48,500
total amount raised in round
194%
Financed 194%
  • Eligible for a tax reduction

Mario Major

Founder

Mario Major is the founder of 10^13th and the creator of the Neuro Universal Language (NUL), a system designed to make human communication clear and understandable in real time.
Driven by personal experience and a deep understanding of neurodivergence, he identified a fundamental gap in how people interpret tone, facial expressions, and intent. This insight led to the development of NUL as a practical solution to reduce ambiguity in everyday interactions.
Mario combines visionary thinking with a strong focus on real-world application. He is actively leading the development of NUL, shaping its product direction, and building the ecosystem around it, including partnerships with academic, clinical, and technology stakeholders.
His ambition is to establish NUL as a global standard for human communication, improving understanding across contexts, cultures, and cognitive differences.

Carl Mourisse

CEO

CEO & Co-Founder, 10^13th

Carl Mourisse is CEO and Co-Founder of 10^13th, bringing extensive C-level leadership experience across multinational corporations, SMEs, and high-growth environments.
He has a proven track record in restructuring, turnaround management, and M&A, with deep expertise in post-merger integration, operational transformation, and value creation. Throughout his career, he has worked closely with private equity firms and family-owned businesses, driving performance and scaling operations.
Carl previously held senior executive roles including COO and Co-CEO at Van De Velde Packaging Group, and Managing Director at Emulco. At Capsugel, part of Pfizer, he held full P&L responsibility for a $600M business across EMEA and Asia, overseeing sales, operations, and corporate functions, and played a key role in the carve-out and sale of the company to KKR.
In addition to his executive roles, Carl is active as a director and advisor to growth-stage companies, supporting strategy, restructuring, and long-term value creation.
At 10^13th, he leads execution, scaling strategy, and organizational development, ensuring the transition from product to a structured, high-growth company.

Laurent Van Tornhout

Co-founder

Chief Commercial Officer & Co-Founder, 10^13th

Laurent Van Tornhout is Chief Commercial Officer and Co-Founder of 10^13th, with over 25 years of experience in product, sales, and business development across global telecom and technology companies.
He currently serves as Regional Sales Director at ZTE and previously held senior leadership roles at Zappware, Telenet, and Ericsson, where he led product strategy, commercial growth, and large-scale deployments across international markets.
As VP Product & Marketing at Zappware and Director Product Management at Telenet, he contributed to the development and scaling of digital platforms used by millions of users. Earlier in his career, he held leadership roles at Ericsson, Nokia Siemens Networks, and Belgacom, building deep expertise in go-to-market execution and enterprise sales.
As Co-Founder of Wellbeing.ai, he gained hands-on experience in launching and positioning an AI-driven product.
At 10^13th, Laurent leads go-to-market strategy, partnerships, and commercial expansion, positioning NUL for adoption across consumer and enterprise markets.

Alain De Mol

CFO

Chief Financial Officer & Co-Founder, 10^13th

Alain De Mol is Chief Financial Officer and Co-Founder of 10^13th, bringing over 25 years of international executive experience across multiple industries, including life sciences, manufacturing, and distribution.
He is currently CEO and Managing Partner of FlorAmor NV, a European market leader in horticultural breeding, sales, and global product out-licensing. In parallel, he is active as a fine art broker, reflecting a strong track record in deal-making and international networks.
Alain has held senior leadership roles at Capsugel (Pfizer), where he was responsible for global supply chain and operations across multiple regions, and played a key role in the carve-out and sale of the business to private equity firm KKR. He has extensive experience in scaling organizations, managing complex international operations, and driving financial performance.
Throughout his career, he has operated in start-up, growth, and turnaround environments, with a consistent focus on execution, structure, and value creation.
At 10^13th, Alain is responsible for financial strategy, structuring, and scaling the company, supporting its transition into a robust and investment-ready organization.

Stefaan Joos

CTO

Chief Technology Officer, 10^13th

Stefaan Joos is Chief Technology Officer at 10^13th, specializing in camera systems, hardware development, and scaling products from concept to mass production.
He is CTO at Camemake, where he leads the design and manufacturing of custom camera modules and full camera products, overseeing the entire process from initial concept to factory production in China.
Stefaan has extensive experience supporting startups and scale-ups in computer vision and hardware, including product definition, prototyping, and on-the-ground manufacturing. He has built and scaled hardware solutions across multiple companies, including leading hardware and supply chain development at Nobi Smart Lamps, where AI-driven products were brought from concept to production.
With a strong background in sensors, AI integration, and factory operations, Stefaan bridges the gap between technology and execution.
At 10^13th, he leads technical development and hardware integration, ensuring NUL can scale into a reliable, production-ready platform.

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €461,500 is available for the Tax Shelter benefit.

Raise summary

Crowd investments €48,500
Committed by others €0
Amount raised €48,500
Minimum round €250,000
Maximum round €3,000,000
Shares in the company (total round) 50%
Pre-money valuation €3,000,000
Post-money valuation min. €3,250,000
Post-money valuation max. €6,000,000